FDA Approves METFORMIN HYDROCHLORIDE — Precision Dose, Inc.

Precision Dose, Inc. received FDA approval for the generic metformin hydrochloride tablet in 2008, enabling it to participate in the generic version of the brand-name diabetic therapy marketed by Metformin Hydrochloride manufacturers. The entry enhances competition in the antidiabetic market, driving down costs for a first-line oral treatment for type 2 diabetes.